Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors
The in vitro anticancer efficacy of a new series of quinazoline-based thiazole derivatives was explored. Three cancer cell lines, MCF-7, HepG2, and A548, as well as the normal Vero cell lines, were tested employing the synthesized quinazoline-based thiazole compounds (4a-j). All of these compounds s...
Main Authors: | M.S. Raghu, H.A. Swarup, T. Shamala, B.S. Prathibha, K. Yogesh Kumar, Fahd Alharethy, M.K. Prashanth, Byong-Hun Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023075084 |
Similar Items
-
Discovery of A Novel Series of Quinazoline–Thiazole Hybrids as Potential Antiproliferative and Anti-Angiogenic Agents
by: Alexandru Șandor, et al.
Published: (2024-02-01) -
Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
by: Abdulmalik S. Altamimi, et al.
Published: (2021-05-01) -
Design of New Quinazoline Derivative as EGFR (Epidermal Growth Factor Receptor) Inhibitor through Molecular Docking and Dynamics Simulation
by: Herlina Rasyid, et al.
Published: (2020-12-01) -
Design, synthesis and docking studies of new hydrazinyl-thiazole derivatives as anticancer and antimicrobial agents
by: Abeer M. El-Naggar, et al.
Published: (2022-07-01) -
Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors
by: Mostafa M. Ghorab, et al.
Published: (2018-01-01)